Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in Italy.

Conclusions: Under routine care, switching to degludec is dominant, compared with continuing previous basal insulin, in Italian patients with T1D or T2D. PMID: 31526202 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research